KOAG

KOAG is a privately held U.S. medical device company focused on vascular closure technologies for interventional cardiology and vascular access settings. Its core product family is the Vascette platform, a peel-and-press topical closure system designed to support rapid hemostasis after cardiac catheterization without direct compression over the arteriotomy site. The company markets Vascette HP, an FDA-cleared hemostatic pad for radial and femoral vascular closure, and also references additional Vascette products for femoral access and PICC line applications. KOAG positions itself as a designer, manufacturer, and marketer of plant-based topical devices for cath lab teams and related vascular intervention workflows.